Evidence map›Paper›PMID 35369382›Full record

ReviewSubstance abuse : research and treatment2022

Substance Use in Healthcare Professionals During the COVID-19 Pandemic in Latin America: A Systematic Review and a Call for Reports.

Jeel Moya-Salazar, Elizabeth Nuñez, Alexis Jaime-Quispe, Nahomi Zuñiga, Isabel L Loaiza-Barboza, Edison A Balabarca, Karina Chicoma-Flores, Betsy Cañari, Hans Contreras-Pulache

Open access · goldAbstract readReview
In one paragraph

Review in Substance abuse : research and treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jeel Moya-SalazarUnit of +Mental Health, Nesh Hubbs, Lima, Peru.ORCID https://orcid.org/0000-0002-7357-4940
Elizabeth NuñezSchool of Medicine, Faculties of Health Science, Universidad Norbert Wiener, Lima, Peru.
Alexis Jaime-QuispeUnit of +Mental Health, Nesh Hubbs, Lima, Peru.ORCID https://orcid.org/0000-0002-3117-3495
Nahomi ZuñigaUnit of +Mental Health, Nesh Hubbs, Lima, Peru.
Isabel L Loaiza-BarbozaSchool of Medicine, Faculties of Health Science, Universidad Norbert Wiener, Lima, Peru.
Edison A BalabarcaSchool of Medicine, Faculties of Health Science, Universidad Norbert Wiener, Lima, Peru.
Karina Chicoma-FloresUnit of +Mental Health, Nesh Hubbs, Lima, Peru.
Betsy CañariUnit of +Mental Health, Nesh Hubbs, Lima, Peru.
Hans Contreras-PulacheSchool of Medicine, Faculties of Health Science, Universidad Norbert Wiener, Lima, Peru.
Universidad Norbert Wiener · PEInstituto Nacional de Salud del Niño · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic has generated a remarkable change in the behaviour of Healthcare workers (HCWs) around the world. However, there is a lack of evidence on substance use among HCWs in Latin America. Therefore, this study aimed to determine the current frequency of substance use among Latin American among HCWs. Methods: We searched 8 databases (PubMed, Scopus, ScientDirect, Web of Science, Cochrane, Scielo, LILACS and Latindex), 4 public prepublication servers (SocArXiv, medRxiv, bioRxiv and Preprints) and Google scholar from 1/9/2019 to 11/1/2021. We determined the frequency of each study based on original studies, scientific letters, and clinical trials in English, Spanish and Portuguese. Results: A total of 17 175 study articles were identified from electronic databases and preprints, and 2 cross-sectional studies conducted in 2020 were included in the qualitative analysis. Both studies included HCWs but did not perform a differential analysis. The first was developed by the Pan-American Health Organization and included interviewees from 35 countries, while the second was conducted with 1145 Brazilian participants. Both studies showed increases in substance use during the pandemic, with alcohol being the most commonly used substance (30%), but PAHO's study reported a 13.8% increase in self-reported heavy-episodic drinking, with differences among genders (males, 15.4%), age groups (highest increase in the 40-49 age group, 16.5%) and area of residence (urban with 14%). The second study showed that 21 32% of participants reported initiating psychoactive substance use, 29.3% added some substance to their initial use and 4% of them had to replace the substance, mainly due to difficulty of access. Other substances of abuse that showed significant increases were tobacco (0.5%) and marijuana (0.3%). Conclusion: Overall, despite the analysis of the 2 studies, the results provided are not a conclusive description of the frequency of substance use by HCWs in Latin America during the COVID-19 pandemic. Further research is required to understand the impact of the pandemic on drug abuse in the region. Protocol Registration: The protocol has been registered on 30 November 2021 on the International Prospective Register of Systematic Reviews (PROSPERO) with ID: CRD420212919700.

Indexed as

alcoholcannabisCOVID-19health professionalsLatin AmericaSubstance abuse

Identifiers

PMID35369382
PMCPMC8968975
OpenAlexW4225642221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.